Drugs / Immunotherapy based on dendritic cells
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 0 | NCT03214939 | Sep 2016 → Sep 2019 | colorectal cancer | Research Institute of Fundamental and Clinical Immunology | Unknown | No outcome recorded |
| Phase 0 | NCT03113019 | Feb 2014 → Feb 2017 | breast cancer | Research Institute of Fundamental and Clinical Immunology | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Immunotherapy based on dendritic cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03113019 ↗ |
| Route | Intravenous | “Intravenous injection of cells” NCT03113019 ↗ |